Feedback / Questions
AMG 337 - NantWorks, Amgen
Astellas: FY 2014 Results
(Astellas)
-
May 25, 2015 -
"Removed from the pipeline list for strategic reasons based on discussion with Amgen"
Licensing / partnership
•
Gastric Cancer • Oncology
http://www.astellas.com/en/ir/library/pdf/4q2015_rd_en.pdf
May 25, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.